Pablo Sarobe

, Spain

Pablo Sarobe, PhD, is professor of Immunology at the University of Navarra and researcher of the Program of Immunology and Immunotherapy at the Center for Applied Medical Research (CIMA), Pamplona, Spain. His area of expertise is Immunology, with emphasis in liver diseases, mainly chronic hepatitis C virus infection and hepatocellular carcinoma. In this field, he has been involved in the characterization of immune responses in these patients as well as in the development of immunotherapeutic strategies. Studies conducted by Prof. Sarobe have helped to understand the role of dendritic cells in chronic HCV infection and the potential use of these cells as vaccines. Thus, his group has developed several vaccination strategies based on the use of dendritic cells or dendritic cell-targeting molecules, leading to clinical procedures combining cell and gene therapy. As a result of this work Prof. Sarobe has authored more than 80 papers in international journals and is co-inventor in 16 patents related to vaccination and immunomodulation, with some of them exploited by biotech companies or in clinical development.

Presentations

General principles of checkpoints inhibition 13 April 2018 11:30 - 11:50
The HDAC inhibitorbelinostat enhances the anti-tumor efficacy of immune checkpoint inhibitors ina murine hepatocellular carcinoma model 14 April 2018 09:00 - 17:00

Abstracts

The HDAC inhibitorbelinostat enhances the anti-tumor efficacy of immune checkpoint inhibitors ina murine hepatocellular carcinoma model

Liver tumours: Experimental and pathophysiology More